Home > Insider Trading > Filing (0000899243-23-002483)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1640266	Voyager Therapeutics Inc.	VYGR	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1192595	I Robert Tepper	201 Brookline Ave, Suite 1401 Boston MA 02115	No	No	Yes	No
1569705	Third Rock Ventures Iii, L.p.	C/O Third Rock Ventures, Llc, 201 Brookline Ave, Suite 1401 Boston MA 02215	No	No	Yes	No
1637299	Trv Gp Iii, Llc	201 Brookline Ave, Suite 1401 Boston MA 02115	No	No	Yes	No
1637300	Third Rock Ventures Gp Iii, L.p.	201 Brookline Ave, Suite 1401 Boston MA 02115	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-01-20	100,000	$9.15	5,328,933	No	4	S	Direct
Common Stock	Disposition	2023-01-23	55,000	$9.06	5,273,933	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	36,701	Direct

Footnotes

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.49, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual manager of TRV GP III LLC is Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
The shares are directly held by Tepper.